Literature DB >> 17584048

Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection.

George L Tipoe1, Tung-Ming Leung, Ming-Wai Hung, Man-Lung Fung.   

Abstract

Our review aims to examine the cellular and molecular mechanisms of cardiovascular protection of green tea polyphenols, particularly epigallocatechin gallate (EGCG), which focuses on the anti-oxidative and anti-inflammatory effects. EGCG is the major and the most active component in green tea. Studies have shown that EGCG protects cellular damage by inhibiting DNA damage and oxidation of LDL. One of the protective properties of EGCG is its ability to scavenge free radicals. EGCG can also reduce the inflammatory response associated with local tissue injuries such as the hepatocellular necrosis in acute liver injury induced by carbon tetrachloride. The protective effect of EGCG is due to its ability to decrease lipid peroxidation, oxidative stress and the production of nitric oxide (NO) radicals by inhibiting the expression of iNOS. EGCG also ameliorates the overproduction of pro-inflammatory cytokines and mediators, reduces the activity of NF-kappaB and AP-1 and the subsequent formation of peroxynitrite with NO and reactive oxygen species. Thus, EGCG effectively mitigates cellular damage by lowering the inflammatory reaction and reducing the lipid peroxidation and NO generated radicals leading to the oxidative stress. Green tea is proposed to be a dietary supplement in the prevention of cardiovascular diseases in which oxidative stress and proinflammation are the principal causes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17584048     DOI: 10.2174/187152907780830905

Source DB:  PubMed          Journal:  Cardiovasc Hematol Disord Drug Targets        ISSN: 1871-529X


  79 in total

1.  Protective effect of green tea polyphenols on bone loss in middle-aged female rats.

Authors:  C-L Shen; P Wang; J Guerrieri; J K Yeh; J-S Wang
Journal:  Osteoporos Int       Date:  2007-12-15       Impact factor: 4.507

Review 2.  Tea and health: preventive and therapeutic usefulness in the elderly?

Authors:  Bradley W Bolling; Chung-Yen Oliver Chen; Jeffrey B Blumberg
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2009-01       Impact factor: 4.294

Review 3.  Interaction between hepatitis C virus and metabolic factors.

Authors:  Yasunori Kawaguchi; Toshihiko Mizuta
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

4.  Epigallocatechin-3-gallate has dual, independent effects on the cardiac sarcoplasmic reticulum/endoplasmic reticulum Ca2+ ATPase.

Authors:  M E Kargacin; T L Emmett; Gary J Kargacin
Journal:  J Muscle Res Cell Motil       Date:  2011-08-05       Impact factor: 2.698

5.  Blood Pressure Is Associated with Tea Consumption: A Cross-sectional Study in a Rural, Elderly Population of Jiangsu China.

Authors:  J-Y Yin; S-Y Duan; F-C Liu; Q-K Yao; S Tu; Y Xu; C-W Pan
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

6.  Neuroprotective effects of white tea against oxidative stress-induced toxicity in striatal cells.

Authors:  M P Almajano; I Vila; S Gines
Journal:  Neurotox Res       Date:  2011-06-23       Impact factor: 3.911

7.  Role of NADPH oxidase in interleukin-4-induced monocyte chemoattractant protein-1 expression in vascular endothelium.

Authors:  Yong Woo Lee; Won Hee Lee; Paul H Kim
Journal:  Inflamm Res       Date:  2010-03-28       Impact factor: 4.575

8.  Tea Consumption and Health-Related Quality of Life in Older Adults.

Authors:  C-W Pan; Q Ma; H-P Sun; Y Xu; N Luo; P Wang
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

9.  Tea consumption and oxidative stress: a cross-sectional analysis of 889 premenopausal women from the Sister Study.

Authors:  Dongyu Zhang; Kelly Ferguson; Melissa Troester; Jeannette T Bensen; Jianwen Cai; Ginger L Milne; Dale P Sandler; Hazel B Nichols
Journal:  Br J Nutr       Date:  2018-12-20       Impact factor: 3.718

10.  Epigallocatechin-3-gallate is a potent phytochemical inhibitor of intimal hyperplasia in the wire-injured carotid artery.

Authors:  Vicente Orozco-Sevilla; Rotem Naftalovich; Thomas Hoffmann; Dennis London; Eric Czernizer; Chenzi Yang; Alan Dardik; Herbert Dardik
Journal:  J Vasc Surg       Date:  2013-03-26       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.